Health

Juvenescence appoints Eileen Jennings-Brown as Chief Technology Officer and strengthens presence in UAE with new partnership and facilities with Masdar City

Jennings-Brown will drive AI and technology strategy and lead the development of capabilities enabling discovery of therapeutics targeting fundamental aging…

2 months ago

LEX Diagnostics Receives FDA 510(k) Clearance and CLIA Waiver for LEX VELO System

Ultra-fast point-of-care molecular diagnostics platform for key respiratory pathogens delivers results in under ten minutes February 16, 2026 05:00 ET…

2 months ago

GN Store Nord A/S – Notice to convene the Annual General Meeting 2026

GN Store Nord’s Annual General Meeting will be held on Wednesday, March 11, 2026, at 10:00 a.m. CET at the…

2 months ago

BioRestorative Announces Closing of $5.0 Million Public Offering

MELVILLE, N.Y., Feb. 13, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a late stage…

2 months ago

Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results

February 13, 2026 16:30 ET  | Source: Natural Alternatives International Inc CARLSBAD, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Natural…

2 months ago

Inotiv Provides Notice Regarding Cybersecurity Incident

February 13, 2026 16:30 ET  | Source: Inotiv, Inc. WEST LAFAYETTE, Ind., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc.…

2 months ago

Psyence BioMed Approves Put Option Agreement with PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway

NEW YORK, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical…

2 months ago

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement

DUBLIN, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics…

2 months ago

Ocular Therapeutix to Announce Topline Data for SOL-1 Phase 3 Superiority Trial in Wet AMD on Tuesday, February 17, 2026

February 13, 2026 17:00 ET  | Source: Ocular Therapeutix, Inc. Ocular to host webcast scheduled for Tuesday, February 17, 2026,…

2 months ago

InnoCare Announces First Patient Dosed in the Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China

BEIJING, Feb. 12, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the…

2 months ago